1 Lubricant Safety Update: Current Research and Advocacy Efforts Global Regulatory Issues IRMA Global Teleconference January 24, 2011 Marc-André LeBlanc.

Slides:



Advertisements
Similar presentations
A study of advertisements in five African countries
Advertisements

EPAA Conference 5 November 2007 Georgette LALIS Enterprise and Industry DG European Commission The international dimension of regulatory acceptance.
Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
Bank Group Engagement in Extractive Industries (EI) Presentation by Tove STRAUSS Governance Division (OSGE.1) African Development Bank Tunis, TUNISIA.
Rectal microbicides Bridget Haire International Rectal Microbicides Advocates (IRMA)
© 2011 Underwriters Laboratories Inc. ICPHSO 2011 Annual Meeting “The Art of Information Sharing” T. Khoi Do.
A reflexive approach to consumer credit regulation Paper presented by Therese Wilson to the Emerging Scholars colloquium 2 July 2010.
Medical Devices Approval Process
Access to Medicine Index 3 rd International Conference for Improving the Use of Medicines Poster 599 Tuesday 15 th November 2011.
Standard 5: Patient Identification and Procedure Matching Nicola Dunbar, Accrediting Agencies Surveyor Workshop, 10 July 2012.
Radiological Devices Advisory Committee Meeting November 18, 2009 John A. DeLucia iCAD, Inc.
Jim Pickett, IRMA/AFC GMHC – January 23, 2013 The Bottom Line on Rectal Microbicide Research.
Helping the people of Canada maintain and improve their health Aider les Canadiens et les Canadiennes à maintenir et à améliorer leur état de santé Path.
1 Are Lubes Safe for Rectal Use? Next Steps for Researchers and Advocates Marc-André LeBlanc, Jim Pickett, Charlene Dezzutti, Edward Fuchs, Pamina Gorbach,
Rectal Microbicides: The Basics October 2008, ESM Marc-André LeBlanc, GCM.
1 Commissioned by PAMSA and German Technical Co-Operation National Certificate in Paper & Pulp Manufacturing NQF Level 2 Understand and deal with HIV/AIDS.
Regulations Relating to Foodstuffs for Infants and Young Children (Foodstuffs, Cosmetics and Disinfectants Act, 1972) Briefing to the Portfolio Committee.
DRM PPANI TRAINING. What is the purpose of a LAPPP The collection, analysis and interpretation of all relevant available facts and information to assess.
The Rectal Microbicides Research Agenda: A Civil Society Update and Consultation Cape Town, South Africa – 7 October 2011 Jim Pickett – IRMA, AIDS Foundation.
Pharmacovigilance obligations of the Pharmaceutical companies in India
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
5 January 2012 – Bangkok, Thailand Jim Pickett – IRMA chair Rectal Microbicide Advocacy AGlobalSnapshot.
Rectal microbicides: Global and European research and advocacy 12 September 2013 Marc-André LeBlanc The Bottom Line on Rectal Microbicide Advocacy.
Implementing Shared Inspection Management Systems Insights from recent WBG research John R. Wille WBG Investment Climate Advisory Services Amman, Jordan.
Presentation by Lia van Ginneken – EMP Secretary & João Salazar – EMP Chairman 21st February 2009.
From choice, a world of possibilities HIV Prevention Report Cards for Sex Workers © IPPF EN/Layla Aerts/Kazakhstan 2013 Lena Luyckfasseel 20 July 2014.
FDA’s Role in Encouraging Innovation in Combination Products Danelle R. Miller, Esq. Regulatory Counsel, Roche Diagnostics For The Combination Products.
CERTIFICATION In the Electronics Recycling Industry © 2007 IAER Web Site - -
Nuclearsafety.gc.ca Joint Congress on Medical Imaging and Radiation Sciences May 28, 2015 e-Doc CNSC Administrative Monetary Penalties Overview.
The IRMA Goodie Bag: Tools to Achieve Rectal Stardom 3 December 2011 Addis Ababa, Ethiopia Jim Pickett – IRMA.
Operational Plan for UNAIDS Action Framework: Addressing Women, Girls, Gender Equality and HIV February 3, 2010.
Venton Jones – NBGMAC Jim Pickett - IRMA Building Support for Global and National Advocacy Network through Social Media.
1 Cross Labeling Combination Products Bradley Merrill Thompson, MBA, JD, RAC Epstein Becker & Green PC.
WHMIS.
Removing regulatory barriers to widespread use of the diaphragm as a potential HIV prevention method Naomi Lince Ibis Reproductive Health.
IRMA Survey on Lubes Used for Anal Sex: Preliminary Results National HIV Prevention Conference December 3, Atlanta Marc-André LeBlanc, IRMA Jim.
Shauna Stahlman, Marjan Javanbakht, Jim Pickett, Marc-Andre LeBlanc, Pamina Gorbach Rectal douching and lubricant use among global web-survey respondents.
June 2014 Marc-André LeBlanc What’s being done about lubricant safety?
“Yes, Africa Needs Rectal Microbicides” IRMA/AVAC teleconference September 27, 2011 Jim Pickett, IRMA Chair 1 Developing an African rectal microbicide.
The Joy of Tech: IRMA as a Model for Maximizing Electronic Communications to Build and Nurture an Advocacy Network May 24, 2010 Microbicides Pittsburgh.
Rolling Resistance Standards Work at ISO (TC31 WG6) Prepared for GRB Review 19 Sep 2011 Angela Wolynski WG6 Convenor Informal document GRB (54th.
FDA Regulatory and Compliance Symposium
WHO Workshop on Assessment of Bioequivalence Data Addis Ababa, 31. August – 3. September 2010 Selection of comparators Compiled by Jan Welink WHO Workshop.
Behind the Mirror of Safety Steve Danon Director, Risk Control Services Marcotte Insurance Agency.
IRMA Survey on Lubes Used for Anal Sex IRMA Global Teleconference May 14, 2009 Marc-André LeBlanc, IRMA Jim Pickett, IRMA Marjan Javanbakht MPH, PhD, UCLA.
Rectal microbicides advocacy Issues, work and collaboration Kim Mulji UK rectal microbicides working group.
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
Workshop on Accreditation of Bodies Certifying Medical Devices Kiev, November 2014.
Torbay Council Partnerships Review August PricewaterhouseCoopers LLP Date Page 2 Torbay Council Partnerships Background The Audit Commission defines.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
MEDICINES CONTROL AUTHORITY OF ZIMBABWE
NRC’s 10 CFR Part 37 Program Review of Radioactive Source Security
Food Additives Project
Is medical revalidation building trust and assurance in doctors
Presentation by Alexis Floris Nkurunziza
U.S. FDA Center for Devices and Radiological Health Update
Premarket Notification 510(k) process
Irena Prat and Josée Hansen World Health Organization
CDRH 2010 Strategic Priorities
Regulatory Issues in China
Paul Boase, Chair, Transport Canada Jill Collins, CSA Val Todd, CCMTA
Melanie Cummings Regulatory Specialist
Cathy Hughes and Neil Crosby
STANDARDS AND ADVOCACY COMMITTEE
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
2 A prescription drug product label is a compilation of information about the safe and effective use of the product prepared by the.
About EverydayComply A Solution designed to:
Difficult to prevent reuse of single use devices
Presentation transcript:

1 Lubricant Safety Update: Current Research and Advocacy Efforts Global Regulatory Issues IRMA Global Teleconference January 24, 2011 Marc-André LeBlanc IRMA Secretary, Lube Wrangler

Regulation 2

Regulators in various countries classify lubes differently, depending on claims made by manufacturers Application of different sets safety criteria for exact same product in different countries U.S. classifies lubes as medical devices Canada classifies them as cosmetics 3 IRMA Lube Safety Working Group

Regulation Safety criteria for medical devices usually stricter than cosmetics criteria IRMA – current criteria insufficient based on info from lube studies to date U.S. simply requires data from studies that test whether lubes irritate rabbit vaginas Insufficient re: safety in human rectums 4 IRMA Lube Safety Working Group

Regulation In some contexts, some lubes are on the market w/out any regulatory approval Some regulatory agencies have little to no power or resources to: force manufacturers to seek regulatory approval take action regarding products that may not be safe 5 IRMA Lube Safety Working Group

Regulation Even in jurisdictions where : Regulatory agencies have very clear and stringent safety criteria Power and resources to enforce rigorously May still be no requirement to demonstrate safety for rectal use Manufacturers rarely indicate product intended for that use 6 IRMA Lube Safety Working Group

Regulation – lack of clarity moment #1 No clarity around safety tests to recommend, even if regulations demanded them Regulators likely to be hesitant to enforce tests that would yield limited safety info Here’s the rub 7 IRMA Lube Safety Working Group

Lack of clarity moment #2 Even if/when we know which lubes are better than others… How does that translate into HIV/STI risk? 8 IRMA Lube Safety Working Group

What is IRMA doing? Urge researchers to test lubes for rectal safety and to share findings Facilitate dialogue leading researchers/advocates in Lube Safety Working Group (wanna join?) Compile articles, studies maintain background document 9

What is IRMA doing? Make IRMA’s list of most widely- used lubes available to anyone interested in testing lubes Monitor how regulatory agencies in various countries address lube safety Engage with lube manufacturers Keep IRMA membership updated 10

Conclusions Water-based lubes don’t look great BASED ON THE TESTS CONDUCTED TO DATE We don’t know how this translates into real-world use, real-world risk Is there a commitment to find out? Can we ever imagine advocating for AI without lubricant? 11

12 o Safety of lubricants for rectal use: Safety of lubricants for rectal use: A fact sheet for HIV educators and advocates o Safety of lubricants for rectal use: Questions & Answers for HIV educators and advocates Safety of lubricants for rectal use: Questions & Answers for HIV educators and advocates rectalmicrobicides.org irma-rectalmicrobicides.blogspot.com

13 IRMA Lube Safety Working Group

Questions? 14

Thank you Marc-André LeBlanc 15